Navigation Links
iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction
Date:7/10/2008

Continues to Surpass Competition in Most Categories of Customer

Satisfaction, According to MD Buyline

NASHUA, N.H., July 10 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced that the Company has achieved record-high customer satisfaction ratings in the Mammography CAD market, according to the independent healthcare research group MD Buyline.

In MD Buyline's User Satisfaction Report for the first two quarters of 2008, iCAD remains #1 in mammography CAD for user satisfaction in system performance, system reliability, installation/implementation, applications training, service response time and service repair quality compared to Hologic/R2. Additionally, iCAD has attained record-high customer service ratings in the categories of System Reliability, Service Repair Quality and overall service and quality.

"We are pleased to see that according to these results, we have been able to maintain the industry's best customer satisfaction ratings this year," said Ken Ferry, President and CEO of iCAD, Inc. "It is even more exciting for iCAD to have achieved its all time high rankings for several of the categories in the report. iCAD is dedicated to delivering superior CAD solutions and customer service that enable radiologists to detect the hardest to find cancers earlier. We thank iCAD users for these high rankings and will continue our mission of providing our customers with first class service and support."

About MD Buyline

MD Buyline provides the most comprehensive database of information on healthcare products. Their data assists healthcare providers through every phase of the purchasing process from researching Emerging Technologies to final negotiations. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies. For MDBuyline, contact Rod Faulkner, analyst at 214-891-6796 or via e-mail at rod.faulkner @mdbuyline.com

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by more than 2,200 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks at 603-882-5200 x7944, or via email at
ddeptula@icadmed.com For Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &

Associates at 212-838-3777 x6604 or via email at icad@lhai.com

For Public Relations, contact Jill Testagrossa of Schwartz Communications at

781-684-0770 or via e-mail at icad@schwartz-pr.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe," "demonstrate," "intend," "expect," "estimate," "anticipate," "likely," and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.


'/>"/>
SOURCE iCAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation
2. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
3. Companion Data Services Achieves ISO Certification for Quality Management
4. Animal Dermatology Clinic - San Diego Announces Dr. Brett Wildermuth, DVM, Achieves Diplomate Status With the American College of Veterinary Dermatology
5. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
6. All Childrens Hospital Achieves ISBT 128 Compliance With Mediwares HCLL Blood Bank System
7. A guided broncoscope achieves biopsy of 75 percent pulmonary nodules without puncture or surgery
8. Paramed Systems Achieves Significant Business Milestone in the Offshore Oil and Gas Evacuation Market
9. Blue Cross and Blue Shield of North Carolina Achieves Bridges to Excellence Certification
10. Highmark Medicare Services Achieves Certification to COPC-2000(R) CSP Standard
11. GHX Achieves SAS 70 Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology: